| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.34 | 9e-22 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.3 | 6e-17 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.37 | 2e-16 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-13 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-11 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.26 | 1e-11 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.35 | 3e-10 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-10 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-09 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-09 |